| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2724 | Intervenolin | Natural potent inhibitor of H. pylori DHODH, having greater efficacy for treatment of H. pylori infection |
|
| DCC2725 | Intoplicine | Inhibitor of both topoisomerase I and II via intercalating DNA helix |
|
| DCC2726 | Inuloxin A | Natural Activator of Programmed Cell Death, leading to membrane damage, mitochondria alteration, chromatin condensation, and ROS accumulation |
|
| DCC2727 | Inz-4 [1585213-98-4] | Novel Potent Fungal-Selective Inhibitor of Mitochondrial Cytochrome bc1 |
|
| DCC2728 | Iodiconazole | Novel antifungal agent, exhibiting broad spectrum and potent activity against 12 kinds of clinically pathogenic fungi |
|
| DCC2729 | Iodoclorgyline | Selective monoamine oxidase A inhibitor |
|
| DCC2730 | Ipcs-1 | Novel inhibitor of the plant inositol phosphorylceramide synthase ((IPCS), demonstrating herbicidal activity |
|
| DCC2731 | Iperoxo-bqca C6 | Muscarinic Acetylcholine Receptor Hybrid Ligand, possessing noticeable M2/M4 mAChR selectivity |
|
| DCC2732 | Ipi-269609 | Orally bioavailable inhibitor of Hedgehog signaling, inhibiting tumor initiation and metastasis in pancreatic cancer |
|
| DCC2733 | Ipomeamarone | Natural toxic furanoterpenoid found in mold-damaged sweet potatoes |
|
| DCC2734 | Ipomoeassin F | Natural inhibitor of the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor, binding Sec61α to Inhibit Protein Translocation |
|
| DCC2735 | Ipr-2025 | Novel inhibitor of glioblastoma multiforme (GBM), inhibiting cell viability of low-passage patient-derived GBM spheroids, blocking tube-formation of endothelial cells in Matrigel, showing no effect on primary hematopoietic CD34+ progenitor spheroids or as |
|
| DCC2736 | ipr-456 | Inhibitor of the uPAR·uPA protein-protein interaction, blocking cancer cell invasion |
|
| DCC2737 | Iproclozide | Irreversible and nonselective Monoamine_oxidase_inhibitor>monoamine oxidase inhibitor (MAOI) |
|
| DCC2738 | Ips-02001 | Novel inhibitor of protein-protein interaction (PPI), targeting integrin αvβ3-osteopontin interface, blocking OC maturation from murine bone marrow-derived macrophages, as well as the resorptive function of OCs, impairing downstream signaling of integrin |
|
| DCC2739 | Ipsalazide | Sulfasalazine analog, releasing 5-aminosalicylic acid and a nontoxic carrier molecule in the gastrointestinal tract |
|
| DCC2740 | Iqs-01.01rs | Novel potent inverse agonist of the chemokine receptor CXCR4, preventing CXCL12-mediated chemotaxis and triggering apoptosis in a panel of 18 cell lines and primary cultures, with superior mobilizing properties in vivo |
|
| DCC2741 | Ir-1061 | NIR-II cyanine dye for cancer treatment and diagnosis |
|
| DCC2742 | Irak Inhibitor 3 | Novel interleukin-1 (IL-I) receptor-associated kinase (IRAK) modulator |
|
| DCC2743 | Irak3 Degrader 23 | Novel potent and selective degrader of IRAK3, inducing proteasome-dependent degradation of IRAK3 and showing both CRBN and IRAK3 binding for activity |
|
| DCC2744 | Irak4-in-13 | Novel Orally Efficacious IRAK4 Inhibitor, Targeting MyD88L265P Mutant Diffuse Large B Cell Lymphoma |
|
| DCC2745 | Irc-083864 | Novel inhibitor of CDC25 phosphatases, actively against human cancer cells |
|
| DCC2746 | ire1-in-vii | Inhibitor of IRE1 endoribonuclease activity, strongly inhibiting XBP-1 splicing in an in vivo model of acute endoplasmic reticulum stress. |
|
| DCC2747 | Irl-1620 | ET B receptor agonist, showing anti-apoptotic activity and protecting neural cells in rats with cerebral ischemia |
|
| DCC2748 | Isam-c032 | Novel potent hA2BAR antagonist (Ki = 3.66 nM) |
|
| DCC2749 | Isatin-o | Neutral BBB crossing reactivator for acetylcholinesterase inhibited by paraoxon, also acting as anticonvulsant |
|
| DCC2750 | Isbogrel | Selective thromboxane A2 (TXA2) synthase inhibitor |
|
| DCC2751 | Isir-005 | Natural Stabilizer of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface |
|
| DCC2752 | Iso-dehydrozingerone | Novel osteoclastogenesis inhibitor, preventing ovariectomy-induced osteoporosis in ddY mice |
|
| DCC2753 | Isofagomine | Iminosugar, binding selectively to N370S glucocerebrosidase and restoring its correct conformation and, consequently, enhancing its activity |
|
